9
Views
27
CrossRef citations to date
0
Altmetric
Research Article

Potentiation of Lethality in Mice by Combinations of Pentazocine and Tripelennamine

, &
Pages 17-23 | Published online: 25 Sep 2008

References

  • American Broadcasting System. T's and Blues: The New Killer. WLS‐TV, Chicago August 11, 1978
  • Parachini A. Chicago Sun Times March 19, 1978; 31(25)64
  • Parachini A. Chicago Sun Times March 20, 1978; 31(40)3
  • Chicago Tribune March 20, 1978; 131(79)3, Section 1
  • Showalter C. V., Moore L. Abuse of pentazocine and tripelennamine. J. Am. Med. Assoc. 1978; 239: 1610
  • Illinois Dangerous Drugs Commission, Personal communication from Thomas Kirkpatrick, Director
  • Waller D. P., Katz N. L., Morris R. W. Potentiation of lethality in mice by combinations of pentazocine (P) and tripelennamine (T). Fed. Proc. 1979; 38(3)436
  • Litchfield J. T., Wilcoxan F. A simplified method of evaluating dose effect experiments. J. Pharmacol. Exp. Ther. 1949; 96: 99
  • Harris L. S., Pierson A. K. Some narcotic antagonists in the benzomorphan series. J. Pharmacol. Exp. Ther. 1964; 143: 141
  • Hoppe J. O., Lands A. M. The toxicologic properties of N,N‐dimethyl‐N'‐(3‐thenyl)‐N'‐(2‐pyridyl)ethylenediamine hydrochloride (thenfadil): A new antihistaminic drug. J. Pharmacol. Exp. Ther. 1949; 97: 371
  • Pentazocine abuse rises‐Schedule IV status proposed. FDA Drug Bull. 1978; 8: 34
  • , Personal Communication from William Harvey, MD, Director, Narcotic Service Council, 2305 St. Louis Avenue, St. Louis, Missouri 63106
  • , Personal Communication from David E. Smith, MD, Medical Director, Haight‐Ashbury Free Medical Clinic, 558 Clayton Street, San Francisco, California 94117
  • Williams J. M., Maickel R. P., Spratto G. R. Increased sensitivity of morphine‐dependent rats to drugs having central nervous system stimulating component. Pharmacologist 1978; 20: 242
  • Lahmeyer H. W., Steingold R. G. Pentazocine and tripelennamine‐A drug abuse epidemic?, Submitted for publication

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.